Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Albendazole Dose and Interval on Brugia Malayi Clearance
NCT00511004Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2007
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of albendazole in lymphatic filariasis (LF), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2007; status: completed.
02
Drugs
albendazole
03
Conditions
lymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT00511004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511004.